Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Owens & Minor ( (OMI) ) is now available.
On February 28, 2025, Owens & Minor announced its financial results for the fourth quarter and full year of 2024, highlighting a total debt reduction of $647 million over two years. The company is in active discussions to potentially sell its Products & Healthcare Services segment and has authorized a $100 million share repurchase program. The 2025 financial outlook indicates expectations for double-digit growth in adjusted EBITDA and EPS, with a focus on the high-growth Patient Direct segment.
More about Owens & Minor
Owens & Minor operates in the healthcare industry, focusing on providing medical products and healthcare services. The company is known for its Patient Direct platform, which supports home-based care for patients with chronic conditions. Owens & Minor is actively working on optimizing its product portfolio and enhancing its distribution capabilities.
YTD Price Performance: -46.38%
Average Trading Volume: 1,068,460
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $531.3M
For detailed information about OMI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue